Cao Shanren, Zhao Chun, Zhang Junqiang, Wu Xun, Guo Xirong, Ling Xiufeng
State Key Laboratory of Reproductive Medicine, Department of Reproduction, Nanjing Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Nanjing, 210004, Jiangsu Province, China.
J Assist Reprod Genet. 2014 May;31(5):577-81. doi: 10.1007/s10815-014-0203-6. Epub 2014 Mar 9.
Vitrification significantly improves the rates of blastocyst survival and clinical pregnancy following frozen embryo transfer (FET). However, ice crystal formation during the freezing process reduces the blastocyst survival rate. Artificial shrinkage (AS) prior to blastocyst vitrification decreases the formation of ice crystals, increasing the blastocyst survival rate. The aim of this study was to identify an efficient AS method to improve blastocyst survival rates following vitrification.
Use of the 29-gauge needle AS and Laser pulse AS methods prior to vitrification was compared in terms of the impacts on the rates of blastocyst survival in FET cycles, blastocyst hatching, clinical pregnancy after transfer, embryo implantation, abortion, gestational duration and birth weight.
In total, 438 blastocysts in 219 cycles were thawed, resulting in survival of 407 (92.9 %). Of these, 213 cycles were transferred, resulting in 129 clinical pregnancies (60.6 %) and 140 successful births. There were no differences between the two methods in the rates of blastocyst survival, clinical pregnancy, embryo implantation and abortion. However, the 29-gauge needle AS group was associated with a significantly lower blastocyst hatching rate (83.6 % vs. 91.2 %), shorter average gestational duration (37.36 ± 2.34 vs. 38.06 ± 1.76), and higher premature birth rate (40.00 % vs. 21.15 %) compared with Laser pulse AS group.
No significant differences in the effectiveness of the two methods applied prior to blastocyst vitrification were observed before birth, while after birth, a significantly improved clinical outcome was obtained with laser pulse AS indicating that this is a more effective pre-processing method for blastocyst vitrification.
玻璃化冷冻显著提高了冷冻胚胎移植(FET)后囊胚的存活率和临床妊娠率。然而,冷冻过程中冰晶的形成降低了囊胚存活率。囊胚玻璃化冷冻前进行人工收缩(AS)可减少冰晶形成,提高囊胚存活率。本研究的目的是确定一种有效的AS方法,以提高玻璃化冷冻后囊胚的存活率。
比较玻璃化冷冻前使用29号针头AS法和激光脉冲AS法对FET周期中囊胚存活率、囊胚孵化、移植后临床妊娠、胚胎着床、流产、孕周和出生体重的影响。
共解冻219个周期中的438个囊胚,407个(92.9%)存活。其中,213个周期进行了移植,129例临床妊娠(60.6%),140例成功分娩。两种方法在囊胚存活率、临床妊娠、胚胎着床和流产率方面无差异。然而,与激光脉冲AS组相比,29号针头AS组的囊胚孵化率显著较低(83.6%对91.2%),平均孕周较短(37.36±2.34对38.06±1.76),早产率较高(40.00%对21.15%)。
在出生前,未观察到囊胚玻璃化冷冻前应用的两种方法在有效性上有显著差异,而出生后,激光脉冲AS获得了显著改善的临床结局,表明这是一种更有效的囊胚玻璃化冷冻预处理方法。